^
Association details:
Biomarker:AGR3 expression
Cancer:Breast Cancer
Drug:tamoxifen (Estrogen receptor antagonist)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
Title:

Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer

Published date:
09/14/2021
Excerpt:
AGR3 expression exhibited a positive correlation to cell viability. Besides, AGR3 promoted tamoxifen resistance in breast cancer....AGR3 is associated with estrogen and promotes tamoxifen resistance in breast cancer.
DOI:
10.1007/s10549-021-06385-3